Synthetic Studies on an Antitumor Antibiotic, Bleomycin. XII. Preparation of an L-2, 3-Diaminopropionic Acid Derivative as a Synthetic Intermediate

Three methods have been developed for the preparation of (S)-3-amino-2-tert-butoxycar-bonylaminopropionamide suitably protected for use in the total synthesis of bleomycin.

Saved in:
Bibliographic Details
Published inChemical & pharmaceutical bulletin Vol. 33; no. 2; pp. 509 - 514
Main Authors YAMASHITA, HARUO, KITTAKA, ATSUSHI, IIMORI, TAKAMASA, OTSUKA, MASAMI, OHNO, MASAJI, KOBAYASHI, SUSUMU
Format Journal Article
LanguageEnglish
Published Tokyo The Pharmaceutical Society of Japan 1985
公益社団法人日本薬学会
Maruzen
Subjects
Online AccessGet full text
ISSN0009-2363
1347-5223
DOI10.1248/cpb.33.509

Cover

Loading…
Abstract Three methods have been developed for the preparation of (S)-3-amino-2-tert-butoxycar-bonylaminopropionamide suitably protected for use in the total synthesis of bleomycin.
AbstractList Three methods have been developed for the preparation of (S)-3-amino-2-tert-butoxycar-bonylaminopropionamide suitably protected for use in the total synthesis of bleomycin.
Author OTSUKA, MASAMI
KITTAKA, ATSUSHI
OHNO, MASAJI
YAMASHITA, HARUO
KOBAYASHI, SUSUMU
IIMORI, TAKAMASA
Author_FL OTSUKA MASAMI
KOBAYASHI SUSUMU
IIMORI TAKAMASA
YAMASHITA HARUO
KITTAKA ATSUSHI
OHNO MASAJI
Author_FL_xml – sequence: 1
  fullname: OTSUKA MASAMI
– sequence: 2
  fullname: KITTAKA ATSUSHI
– sequence: 3
  fullname: IIMORI TAKAMASA
– sequence: 4
  fullname: YAMASHITA HARUO
– sequence: 5
  fullname: KOBAYASHI SUSUMU
– sequence: 6
  fullname: OHNO MASAJI
Author_xml – sequence: 1
  fullname: YAMASHITA, HARUO
– sequence: 1
  fullname: KITTAKA, ATSUSHI
– sequence: 1
  fullname: IIMORI, TAKAMASA
– sequence: 1
  fullname: OTSUKA, MASAMI
– sequence: 1
  fullname: OHNO, MASAJI
– sequence: 1
  fullname: KOBAYASHI, SUSUMU
BackLink https://cir.nii.ac.jp/crid/1571698602415100160$$DView record in CiNii
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=9145665$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/2410151$$D View this record in MEDLINE/PubMed
BookMark eNptkUtrGzEUhUVJSZ20m-4LWpQuSsbVY6QZLV2nD4OhhbTQ3XBHvm4UZjSOJAf8O_qHq4kHB0o3kuB89-hwzwU584NHQl5zNueirD_YXTuXcq6YeUZmXJZVoYSQZ2TGGDOFkFq-IBcx3jEmFKvkOTkXJWdc8Rn5c3Pw6RaTs_Qm7TcOIx08BU8XPrm074fw-GrdkJEr-rHDoT9Y5-f012o1p98D7iBAcnlo2I5z60JcUVlcO-idH3Zh2GUtuy-s29BrDO4h0w9IIVKgT5-vfMLQ48ZBwpfk-Ra6iK-m-5L8_Pzpx_Jrsf72ZbVcrAsr69IUUqPQWNuSKbWRpTTbGhTjaBCB15zJujVGGWwZ1sbWooVKSW7bsgSLrNzIS_Lu6JtT3u8xpqZ30WLXgcdhH5tKC650xTP4ZgL3bc7Y7ILrIRyaaYtZfzvpEC102wDeunjCDC-V1ipj74-YDUOMAbcngrNmLLLJRTZSNrnIDLN_YOvS46JTANf9f2SK4Z3L9HhyVXFtas1yVMUZ45plbHnE7mKC33gKASEX0eHoyI2qR1dxPLL5k3oLoUEv_wLsVsHq
CODEN CPBTAL
CitedBy_id crossref_primary_10_1002_pep2_24058
crossref_primary_10_1016_j_tet_2005_04_046
crossref_primary_10_3987_COM_04_10214
crossref_primary_10_1016_S0960_894X_01_80184_0
crossref_primary_10_1002_psc_2968
crossref_primary_10_1016_j_jfluchem_2005_04_008
crossref_primary_10_1016_S0040_4039_00_98029_8
crossref_primary_10_1021_ja012741l
crossref_primary_10_1016_S0040_4020_88_90018_X
crossref_primary_10_1021_jo9904718
crossref_primary_10_1016_S0040_4039_00_84868_6
crossref_primary_10_3390_molecules25061313
crossref_primary_10_1016_S0040_4020_01_00090_4
crossref_primary_10_1021_cr100127y
crossref_primary_10_1021_ol026782d
crossref_primary_10_1016_0040_4039_95_01544_2
crossref_primary_10_1016_S0957_4166_00_86019_X
crossref_primary_10_1021_ja412298c
crossref_primary_10_1002_ange_200500927
crossref_primary_10_1002_jlac_1991199101227
crossref_primary_10_1021_jo9702756
crossref_primary_10_1021_jo951958t
crossref_primary_10_1021_jo961598p
crossref_primary_10_1021_jo9612537
crossref_primary_10_1002_jhet_5570340516
crossref_primary_10_1016_S0040_4020_01_86376_6
crossref_primary_10_1248_cpb_49_1272
crossref_primary_10_1002_ejoc_201000042
crossref_primary_10_1016_j_tet_2009_07_054
crossref_primary_10_1016_S0040_4020_88_90017_8
crossref_primary_10_1021_cr0406561
crossref_primary_10_1016_0040_4020_95_00446_F
crossref_primary_10_1016_j_tet_2004_06_034
crossref_primary_10_1002_anie_200500927
crossref_primary_10_1016_S0040_4039_00_60843_2
crossref_primary_10_1021_jo061692y
crossref_primary_10_1002__SICI_1099_0690_199805_1998_5_777__AID_EJOC777_3_0_CO_2_W
crossref_primary_10_1080_00397910600948039
crossref_primary_10_1002_chin_198529335
crossref_primary_10_1021_jo000071g
crossref_primary_10_1002_ejoc_201200496
ContentType Journal Article
Copyright The Pharmaceutical Society of Japan
1985 INIST-CNRS
Copyright_xml – notice: The Pharmaceutical Society of Japan
– notice: 1985 INIST-CNRS
DBID RYH
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1248/cpb.33.509
DatabaseName CiNii Complete
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
Chemistry
EISSN 1347-5223
EndPage 514
ExternalDocumentID 2410151
9145665
10_1248_cpb_33_509
110003625401
article_cpb1958_33_2_33_2_509_article_char_en
Genre Journal Article
GroupedDBID ---
.55
.GJ
2WC
3O-
53G
5GY
6J9
ACGFO
ACIWK
ACPRK
ADBBV
AENEX
AFRAH
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
DU5
EBS
EJD
F5P
GX1
HH5
JSF
JSH
KQ8
L7B
OK1
P2P
RJT
RZJ
TKC
TR2
VH1
X7M
ZGI
RYH
29B
AAYXX
BKOMP
CITATION
E3Z
JMI
MOJWN
X7J
XSB
ZE2
ZY4
ABTAH
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c3849-36e26e8c4055d3439f8a501e9eea181038b9959eb0e89c82ba7531cb44ace04d3
ISSN 0009-2363
IngestDate Fri Jul 11 06:30:39 EDT 2025
Sat Sep 28 08:35:07 EDT 2024
Wed Apr 02 07:12:59 EDT 2025
Thu Apr 24 22:51:15 EDT 2025
Tue Jul 01 03:06:12 EDT 2025
Fri Jun 27 00:06:37 EDT 2025
Wed Sep 03 06:19:33 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Diamine
Antibiotic
Aminoamide
Aliphatic compound
Aminoacid
Saturated compound
Hofmann reaction
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3849-36e26e8c4055d3439f8a501e9eea181038b9959eb0e89c82ba7531cb44ace04d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/cpb1958/33/2/33_2_509/_article/-char/en
PMID 2410151
PQID 76215671
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_76215671
pubmed_primary_2410151
pascalfrancis_primary_9145665
crossref_primary_10_1248_cpb_33_509
crossref_citationtrail_10_1248_cpb_33_509
nii_cinii_1571698602415100160
jstage_primary_article_cpb1958_33_2_33_2_509_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 19850000
PublicationDateYYYYMMDD 1985-01-01
PublicationDate_xml – year: 1985
  text: 19850000
PublicationDecade 1980
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
– name: Japan
PublicationTitle Chemical & pharmaceutical bulletin
PublicationTitleAlternate Chem. Pharm. Bull.
PublicationYear 1985
Publisher The Pharmaceutical Society of Japan
公益社団法人日本薬学会
Maruzen
Publisher_xml – name: The Pharmaceutical Society of Japan
– name: 公益社団法人日本薬学会
– name: Maruzen
References 10) L. Benoiton, Can. J. Chem., 46, 1549 (1968).
8) J. P. Greenstein and M. Winitz, "Chemistry of the Amino Acids," Vol. III, John Wiley-and Sons, Inc., New York, 1961, p. 2463.
d) Part IV: M. Otsuka, M. Yoshida, S. Kobayashi, M. Ohno, Y. Umezawa, and H. Morishima, Tetrahedron Lett., 22, 2109 (1981
9) S. Takagi, H. Tsukatani, and K. Hayashi, Chem. Pharm. Bull., 7, 616 (1959).
13) H. Yamashita, T. Iimori, M. Otsuka, S. Kobayashi, and M. Ohno, Abstracts of Papers, 103rd Annual Meeting of the Pharmaceutical Society of Japan, Tokyo, April 1983, p. 198.
Hecht, Springer-Verlag, New York, 1979, p. 63
2) T. Takita, Y. Muraoka, T. Nakatani, A. Fujii, Y. Umezawa, H. Naganawa, and H. Umezawa, J. Antibiot., 26, 801 (1978).
c) Part III: T. Takita, Y. Umezawa, S. Saito, H. Morishima, H. Umezawa, Y. Muraoka, M. Suzuki, M. Otsuka, S. Kobayashi, and M. Ohno, Tetrahedron Lett., 22, 671 (1981
g) Part VII: T. Takita, Y. Umezawa, S. Saito, H. Morishima, H. Naganawa, H. Umezawa, T. Tsuchiya, T. Miyabe, S. Kageyama, S. Umezawa, Y. Muraoka, M. Suzuki, M. Otsuka, M. Narita, S. Kobayashi, and M. Ohno, Tetrahedron Lett., 23, 521 (1982
f) Part VI: T. Takita, Y. Umezawa, S. Saito, H. Morishima, H. Umezawa, Y. Muraoka, M. Suzuki, M. Otsuka, S. Kobayashi, M. Ohno, T. Tsuchiya, T. Miyake, and S. Umezawa, Proceedings of the Seventh American Peptide Symposium, ed. by D. H. Rich and E. Gross, 1981, p. 29
k) Part XI: H. Umezawa, T. Takita, Y. Sugiura, M. Otsuka, S. Kobayashi, and M. Ohno, Tetrahedron, 40, 501 (1984).
b) R. B. Sykes, C. M. Cimarusti, D. P. Bonner, K. Bush, D. M. Floyd, N. H. Georgopapadakou, W. H. Koster, W. C. Liu, W. L. Principe, M. L. Rathnum, W. A. Slusarchyk, W. H. Trejo, and J. J. Wells, Nature (London), 291, 498 (1981).
5) T. Kitagawa, T. Ozasa, and H. Taniyama, Yakugaku Zasshi, 89, 285 (1969).
h) Part VIII: M. Narita, M. Otsuka, S. Kobayashi, M. Ohno, Y. Umezawa, H. Morishima, S. Saito, T. Takita, and H. Umezawa, Tetrahedron Lett., 23, 525 (1982
i) Part IX: S. Saito, Y. Umezawa, H. Morishima, T. Takita, H. Umezawa, M. Narita, M. Otsuka, S. Kobayashi, and M. Ohno, Tetrahedron Lett., 23, 529 (1982
e) Part V: M. Otsuka, M. Yoshida, S. Kobayashi, M. Ohno, Y. Sugiura, T. Takita, and H. Umezawa, J. Am. Chem. Soc., 103, 6986 (1981
4) a) A. Imada, K. Kitano, K. Kintaka, M. Muroi, and M. Asai, Nature (London), 289, 590 (1981
6) a) P. Karrer and A. Schlosser, Helv. Chim. Acta, 6, 441 (1923
11) I. Photaki, J. Am. Chem. Soc., 85, 1123 (1963).
7) J. Rundiger, K. Poduska, and M. Zaoral, Collect. Czech. Chem. Commun., 25, 2022 (1960).
b) F. Schneider, Justus Liebigs Ann. Chem., 529, 1 (1937).
b) Part II: Y. Umezawa, H. Morishima, S. Saito, T. Takita, H. Umezawa, S. Kobayashi, M. Otsuka, M. Narita, and M. Ohno, J. Am. Chem. Soc., 102, 6630 (1980
1) a) Part I: Y. Umezawa, H. Morishima, T. Yoshioka, M. Otsuka, and M. Ohno, "Bleomycin," ed. by S. M.
12) O. Mitsunobu, Synthesis, 1981, 1.
3) M. Hashimoto, T. Konomi, and T. Kamiya, J. Am. Chem. Soc., 98, 3023 (1976).
j) Part X: Y. Sugiura, T. Suzuki, M. Otsuka, S. Kobayashi, M. Ohno, T. Takita, and. H. Umezawa, J. Biol. Chem., 258, 1328 (1983
References_xml – reference: 13) H. Yamashita, T. Iimori, M. Otsuka, S. Kobayashi, and M. Ohno, Abstracts of Papers, 103rd Annual Meeting of the Pharmaceutical Society of Japan, Tokyo, April 1983, p. 198.
– reference: j) Part X: Y. Sugiura, T. Suzuki, M. Otsuka, S. Kobayashi, M. Ohno, T. Takita, and. H. Umezawa, J. Biol. Chem., 258, 1328 (1983);
– reference: 6) a) P. Karrer and A. Schlosser, Helv. Chim. Acta, 6, 441 (1923);
– reference: 2) T. Takita, Y. Muraoka, T. Nakatani, A. Fujii, Y. Umezawa, H. Naganawa, and H. Umezawa, J. Antibiot., 26, 801 (1978).
– reference: d) Part IV: M. Otsuka, M. Yoshida, S. Kobayashi, M. Ohno, Y. Umezawa, and H. Morishima, Tetrahedron Lett., 22, 2109 (1981);
– reference: b) R. B. Sykes, C. M. Cimarusti, D. P. Bonner, K. Bush, D. M. Floyd, N. H. Georgopapadakou, W. H. Koster, W. C. Liu, W. L. Principe, M. L. Rathnum, W. A. Slusarchyk, W. H. Trejo, and J. J. Wells, Nature (London), 291, 498 (1981).
– reference: Hecht, Springer-Verlag, New York, 1979, p. 63;
– reference: b) Part II: Y. Umezawa, H. Morishima, S. Saito, T. Takita, H. Umezawa, S. Kobayashi, M. Otsuka, M. Narita, and M. Ohno, J. Am. Chem. Soc., 102, 6630 (1980);
– reference: c) Part III: T. Takita, Y. Umezawa, S. Saito, H. Morishima, H. Umezawa, Y. Muraoka, M. Suzuki, M. Otsuka, S. Kobayashi, and M. Ohno, Tetrahedron Lett., 22, 671 (1981);
– reference: 9) S. Takagi, H. Tsukatani, and K. Hayashi, Chem. Pharm. Bull., 7, 616 (1959).
– reference: f) Part VI: T. Takita, Y. Umezawa, S. Saito, H. Morishima, H. Umezawa, Y. Muraoka, M. Suzuki, M. Otsuka, S. Kobayashi, M. Ohno, T. Tsuchiya, T. Miyake, and S. Umezawa, Proceedings of the Seventh American Peptide Symposium, ed. by D. H. Rich and E. Gross, 1981, p. 29;
– reference: 8) J. P. Greenstein and M. Winitz, "Chemistry of the Amino Acids," Vol. III, John Wiley-and Sons, Inc., New York, 1961, p. 2463.
– reference: i) Part IX: S. Saito, Y. Umezawa, H. Morishima, T. Takita, H. Umezawa, M. Narita, M. Otsuka, S. Kobayashi, and M. Ohno, Tetrahedron Lett., 23, 529 (1982);
– reference: g) Part VII: T. Takita, Y. Umezawa, S. Saito, H. Morishima, H. Naganawa, H. Umezawa, T. Tsuchiya, T. Miyabe, S. Kageyama, S. Umezawa, Y. Muraoka, M. Suzuki, M. Otsuka, M. Narita, S. Kobayashi, and M. Ohno, Tetrahedron Lett., 23, 521 (1982);
– reference: 12) O. Mitsunobu, Synthesis, 1981, 1.
– reference: 4) a) A. Imada, K. Kitano, K. Kintaka, M. Muroi, and M. Asai, Nature (London), 289, 590 (1981);
– reference: 3) M. Hashimoto, T. Konomi, and T. Kamiya, J. Am. Chem. Soc., 98, 3023 (1976).
– reference: 1) a) Part I: Y. Umezawa, H. Morishima, T. Yoshioka, M. Otsuka, and M. Ohno, "Bleomycin," ed. by S. M.
– reference: 7) J. Rundiger, K. Poduska, and M. Zaoral, Collect. Czech. Chem. Commun., 25, 2022 (1960).
– reference: b) F. Schneider, Justus Liebigs Ann. Chem., 529, 1 (1937).
– reference: k) Part XI: H. Umezawa, T. Takita, Y. Sugiura, M. Otsuka, S. Kobayashi, and M. Ohno, Tetrahedron, 40, 501 (1984).
– reference: 10) L. Benoiton, Can. J. Chem., 46, 1549 (1968).
– reference: h) Part VIII: M. Narita, M. Otsuka, S. Kobayashi, M. Ohno, Y. Umezawa, H. Morishima, S. Saito, T. Takita, and H. Umezawa, Tetrahedron Lett., 23, 525 (1982);
– reference: 11) I. Photaki, J. Am. Chem. Soc., 85, 1123 (1963).
– reference: e) Part V: M. Otsuka, M. Yoshida, S. Kobayashi, M. Ohno, Y. Sugiura, T. Takita, and H. Umezawa, J. Am. Chem. Soc., 103, 6986 (1981);
– reference: 5) T. Kitagawa, T. Ozasa, and H. Taniyama, Yakugaku Zasshi, 89, 285 (1969).
SSID ssj0025073
Score 1.2849274
Snippet Three methods have been developed for the preparation of (S)-3-amino-2-tert-butoxycar-bonylaminopropionamide suitably protected for use in the total synthesis...
SourceID proquest
pubmed
pascalfrancis
crossref
nii
jstage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 509
SubjectTerms (S)-3-amino-2-tert-butoxycarbonylaminopropionamide
Alanine - analogs & derivatives
Aliphatic compounds
beta-Alanine - analogs & derivatives
beta-Alanine - chemical synthesis
bleomycin
Bleomycin - chemical synthesis
Chemical Phenomena
Chemistry
Exact sciences and technology
Hofmann rearrangement
L-2, 3-diaminopropionic acid
L-asparagine
L-serine
Mitsunobu reaction
Organic chemistry
Preparations and properties
Title Synthetic Studies on an Antitumor Antibiotic, Bleomycin. XII. Preparation of an L-2, 3-Diaminopropionic Acid Derivative as a Synthetic Intermediate
URI https://www.jstage.jst.go.jp/article/cpb1958/33/2/33_2_509/_article/-char/en
https://cir.nii.ac.jp/crid/1571698602415100160
https://www.ncbi.nlm.nih.gov/pubmed/2410151
https://www.proquest.com/docview/76215671
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Chemical and Pharmaceutical Bulletin, 1985/02/25, Vol.33(2), pp.509-514
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELbawgMv3BULFCyBK6HdLJs4ThyJl6Rs1RaBimilvkVx4oigNlntgbT8DH4xM0k2h1rEIa0syxkf2fHYM874G0JepyqCfTNNDCfVYKDwJDYiWwgjAVVZm1qpicIvuh8_OUfn9smFuNjavtfxWlot1Tj-ceO9kv_hKpQBX_GW7D9wtmkUCiAP_IUUOAzpX_H4yzoH_Q0hV2t3wGHpW4yIANlydVXMy5zKCiApGXmpi6t1nOXj4cXx8Rj9Lyro70ppxAi-hgWE3HiP973zApbXWVbGyPHjDF2W52UwtO8aw9NEw7b_8mCxvIWy7IMfbPAIcIbNvvbOz1UX-Rt4zqaC-Tbz3TJjMs8fsqnHvIBJgUWBywLeEjvMh4cSSfwAMkMs8qCmg8TykAVWSww0nPmHZS3ITKuWfSadspZk8qA7jMDE39RmATwJhjWNLzbjsdvDEtOrggGNNxftTvtvuXGLhf_3BBSTvLdNeIbF65W33iYqvI5aHKzOmi8mXkd9ENWd2Gs7k2XjbYt4psacj5sqPaRvRO9DhQKUaLDnb1mua-I6_eFz810M9FW3iQ2IA6wBd6Hxt23TPRXr9jewMhA-YjvPMvT8jRbw8mkVteX3ZlWpXp3dJ3dru4j61SR_QLZ0_pDs1__lekTP2nuCixHdp6ct5Pr6EfnZzERaSwItchrltJEE2krCiLZyQFEOaEcOaJFiPZCD0XUpoCgFtJUCGi1oRNu-u1LwmJwfTs8Ojow62ogRc2l7Bne05WgZgwUjEg56eiojMTG1p3UEavCES4XYfFpNtPRiaakILH0zVrYNU2piJ3yX7ORFrp-gu6DkOnGVSJWwbQxwJblrpVHicZ4I6Q7Imw2DwriG4seIMJchmuTAzBCYGXIeAjMH5FVDO6sAaG6kelfxuaGpFyWkQTwppLOqBMjbp8AsWEkHZA9mB4wFU1MgghbGpgPl3iwD0cPz3rxpevFMMMAcMSAvN_MohO0JvzlGuS5WixB0LVM4rjkgu9X0aqpC62CKmE__0PUzcgcFuTr1fE52lvOV3gM7YKlelKLxC5xl9jA
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthetic+Studies+on+an+Antitumor+Antibiotic%2C+Bleomycin.+XII.+Preparation+of+an+L-2%2C3-Diaminopropionic+Acid+Derivative+as+a+Synthetic+Intermediate&rft.jtitle=Chemical+%26+pharmaceutical+bulletin&rft.au=%E5%A4%A7%E5%A1%9A+%E9%9B%85%E5%B7%B3&rft.au=%E6%A9%98%E9%AB%98+%E6%95%A6%E5%8F%B2&rft.au=%E9%A3%AF%E6%A3%AE+%E9%9A%86%E6%98%8C&rft.au=%E5%B1%B1%E4%B8%8B+%E6%98%A5%E9%9B%84&rft.date=1985&rft.pub=The+Pharmaceutical+Society+of+Japan&rft.issn=0009-2363&rft.volume=33&rft.issue=2&rft.spage=509&rft.epage=514&rft_id=info:doi/10.1248%2Fcpb.33.509&rft.externalDocID=110003625401
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-2363&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-2363&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-2363&client=summon